A Trial of Intravenous Denileukin Diftitox in Stage III or IV Ovarian Cancer

NCT00880360 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Epithelial Ovarian Cancer
Extraovarian Peritoneal Cancer
Fallopian Tube Carcinoma

Interventions

DRUG: Ontak

Sponsor

The University of Texas Health Science Center at San Antonio